| scholarly article | Q13442814 |
| P50 | author | Balázs Hegedűs | Q39031785 |
| Balázs Döme | Q42748261 | ||
| P2093 | author name string | József Tímár | |
| István Kenessey | |||
| Miklós Garami | |||
| Christine Haberler | |||
| Katalin Bálint | |||
| Violetta Piurkó | |||
| József Virág | |||
| P2860 | cites work | Expression of KIT receptor tyrosine kinase in endothelial cells of juvenile brain tumors | Q24614629 |
| Dual Inhibitor AEE788 Reduces Tumor Growth in Preclinical Models of Medulloblastoma | Q24615472 | ||
| Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression | Q28138812 | ||
| Expression of hypoxia-inducible factor 1? in brain tumors | Q29540607 | ||
| Angiogenesis in brain tumors | Q30310437 | ||
| Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor | Q33937769 | ||
| Molecular events implicated in brain tumor angiogenesis and invasion | Q34056893 | ||
| Protein expression of platelet-derived growth factor receptor correlates with malignant histology and PTEN with survival in childhood gliomas | Q34191508 | ||
| Sunitinib induces PTEN expression and inhibits PDGFR signaling and migration of medulloblastoma cells | Q34380617 | ||
| Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology | Q34435505 | ||
| Expression of a functional VEGFR-1 in tumor cells is a major determinant of anti-PlGF antibodies efficacy | Q35105257 | ||
| Enhanced efficacy of IGF1R inhibition in pediatric glioblastoma by combinatorial targeting of PDGFRα/β. | Q35177853 | ||
| Alternative vascularization mechanisms in cancer: Pathology and therapeutic implications. | Q35570450 | ||
| Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery | Q35746429 | ||
| Functional VEGF and VEGF receptors are expressed in human medulloblastomas | Q36013314 | ||
| Glioblastoma-derived tumor cells induce vasculogenic mimicry through Flk-1 protein activation | Q36098121 | ||
| A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry | Q36884006 | ||
| Angiogenesis in brain tumours | Q36887534 | ||
| New molecular targets in malignant gliomas | Q36997065 | ||
| Evaluation of the expression of C-kit (CD117) in ependymomas and oligodendrogliomas. | Q37261784 | ||
| Bevacizumab for recurrent ependymoma. | Q37459705 | ||
| Small molecule inhibitors in children with malignant gliomas | Q37478343 | ||
| Role of platelet derived growth factor receptor (PDGFR) over-expression and angiogenesis in ependymoma | Q38399886 | ||
| KIT expression and methylation in medulloblastoma and PNET cell lines and tumors. | Q39654005 | ||
| Autocrine VEGF signaling synergizes with EGFR in tumor cells to promote epithelial cancer development | Q39742008 | ||
| Compassionate use of bevacizumab (Avastin) in children and young adults with refractory or recurrent solid tumors | Q39824313 | ||
| Initial testing of the VEGFR inhibitor AZD2171 by the pediatric preclinical testing program | Q40141410 | ||
| Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition. | Q40469450 | ||
| Growth factor receptors and medulloblastoma | Q41118787 | ||
| Tumor vessel biology in pediatric intracranial ependymoma | Q42469833 | ||
| Transdifferentiation of glioblastoma stem-like cells into mural cells drives vasculogenic mimicry in glioblastomas | Q42544373 | ||
| Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment | Q43269529 | ||
| Amplification and overexpression of KIT, PDGFRA, and VEGFR2 in medulloblastomas and primitive neuroectodermal tumors | Q43271629 | ||
| C-kit expression and mutational analysis in medulloblastoma | Q45153003 | ||
| [Small-molecule inhibitors against KIT and PDGFRs especially in GISTs]. | Q45924503 | ||
| Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme | Q46602369 | ||
| CD117 expression in glial tumors | Q46678485 | ||
| Immunohistochemical analysis of platelet-derived growth factor receptor-alpha, -beta, c-kit, c-abl, and arg proteins in glioblastoma: possible implications for patient selection for imatinib mesylate therapy | Q46736774 | ||
| Bevacizumab plus irinotecan in recurrent glioblastoma multiforme | Q46942082 | ||
| Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma. | Q47822182 | ||
| Tumour vasculature and angiogenic profile of paediatric pilocytic astrocytoma; is it much different from glioblastoma? | Q48092052 | ||
| PDGFRB is overexpressed in metastatic medulloblastoma | Q48156716 | ||
| Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas | Q48327574 | ||
| Vascularity and angiogenesis as predictors of growth in optic pathway/hypothalamic gliomas | Q48468939 | ||
| Immunohistochemical markers for prognosis of ependymal neoplasms | Q48505500 | ||
| Are endothelial cell patterns of astrocytomas indicative of grade? | Q48566073 | ||
| Mutational analysis of PDGFR-RAS/MAPK pathway activation in childhood medulloblastoma | Q48675156 | ||
| Bevacizumab and irinotecan in children with recurrent or refractory brain tumors: toxicity and efficacy trends | Q48685934 | ||
| Antiangiogenic metronomic therapy for children with recurrent embryonal brain tumors | Q48794915 | ||
| Incremental increase in VEGFR1⁺ hematopoietic progenitor cells and VEGFR2⁺ endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients | Q50349915 | ||
| Vascular apoptosis and involution in gliomas precede neovascularization: a novel concept for glioma growth and angiogenesis. | Q52539830 | ||
| Molecular alterations of KIT oncogene in gliomas. | Q54962741 | ||
| Bevacizumab and irinotecan in the treatment of children with recurrent/refractory medulloblastoma | Q55463683 | ||
| Intussusceptive microvascular growth in human glioma. | Q55464634 | ||
| Three-dimensional (3D) reconstruction and quantitative analysis of the microvasculature in medulloblastoma and ependymoma subtypes. | Q55469101 | ||
| Different vascular patterns of medulloblastoma and supratentorial primitive neuroectodermal tumors. | Q55476460 | ||
| Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. | Q55476886 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 417-426 | |
| P577 | publication date | 2013-11-05 | |
| P1433 | published in | Pathology Oncology Research | Q26842743 |
| P1476 | title | Angiogenesis and angiogenic tyrosine kinase receptor expression in pediatric brain tumors | |
| P478 | volume | 20 |
Search more.